Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-02

Clinical Trial Update: Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 trial investigating milrinone added to hyperdynamic therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage; the study is terminated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milrinone (milrinone)

Snippet

Sponsor: Indiana University | Conditions: Cerebral Vasospasm | Phase 2 | Status: TERMINATED | Results posted: 2019-07-02